Rades, D.; Cacicedo, J.; Lomidze, D.; Al-Salool, A.; Segedin, B.; Groselj, B.; Schild, S.E.
Prognostic Value of Preclinical Markers after Radiotherapy of Metastatic Spinal Cord Compression—An Additional Analysis of Patients from Two Prospective Trials. Cancers 2022, 14, 2547.
https://doi.org/10.3390/cancers14102547
AMA Style
Rades D, Cacicedo J, Lomidze D, Al-Salool A, Segedin B, Groselj B, Schild SE.
Prognostic Value of Preclinical Markers after Radiotherapy of Metastatic Spinal Cord Compression—An Additional Analysis of Patients from Two Prospective Trials. Cancers. 2022; 14(10):2547.
https://doi.org/10.3390/cancers14102547
Chicago/Turabian Style
Rades, Dirk, Jon Cacicedo, Darejan Lomidze, Ahmed Al-Salool, Barbara Segedin, Blaz Groselj, and Steven E. Schild.
2022. "Prognostic Value of Preclinical Markers after Radiotherapy of Metastatic Spinal Cord Compression—An Additional Analysis of Patients from Two Prospective Trials" Cancers 14, no. 10: 2547.
https://doi.org/10.3390/cancers14102547
APA Style
Rades, D., Cacicedo, J., Lomidze, D., Al-Salool, A., Segedin, B., Groselj, B., & Schild, S. E.
(2022). Prognostic Value of Preclinical Markers after Radiotherapy of Metastatic Spinal Cord Compression—An Additional Analysis of Patients from Two Prospective Trials. Cancers, 14(10), 2547.
https://doi.org/10.3390/cancers14102547
